Pharmacy Research UK (PRUK) and the British Oncology Pharmacy Association (BOPA) have announced a new funding partnership for 2016 to allow pharmacists in oncology and haematology pharmacy to undertake research.
The BOPA-PRUK Research Awards will support projects in translational and health service research related to oncology and haematology pharmacy with a focus on patient benefit and provide a platform for novice researchers to engage in research.
Through these awards PRUK and BOPA aim to build the capacity for research within oncology and haematology pharmacy, provide evidence to inform healthcare policy and to highlight the vital role of pharmacists and pharmacy technicians in the wider healthcare community.
Dr Rachel Joynes, Head of Research and Evaluation at PRUK, said, ‘We are delighted to be announcing this new partnership with BOPA which we hope will not only allow both pharmacists and pharmacy technicians to undertake research but also present an opportunity for those new to research to lead their first project.’
Carl Booth, Chair of the BOPA Audit and Research Sub-Committee, also commented, ‘BOPA is incredibly excited to be funding our first research projects to build the base of evidence in oncology and haematology pharmacy. We hope this funding will allow our members to explore previously unanswered questions and will support the development of new skills and future opportunities’.
Successful applicants will be invited to present their work at the BOPA annual symposium in 2017.
Applications for awards of up to £5,000 over 12 months will be considered from pharmacists and pharmacy technicians.
The scheme will open for application on February 1st 2016, with further information available on the PRUK website: www.pharmacyresearchuk.org.
For more information, email Practice.Research@rpharms.com.
